An Endocytosis Pathway Initiated Through Neuropilin-1 and Regulated by Nutrient Availability
Overview
Authors
Affiliations
Neuropilins (NRPs) are trans-membrane receptors involved in axon guidance and vascular development. Many growth factors and other signalling molecules bind to NRPs through a carboxy (C)-terminal, basic sequence motif (C-end Rule or CendR motif). Peptides with this motif (CendR peptides) are taken up into cells by endocytosis. Tumour-homing CendR peptides penetrate through tumour tissue and have shown utility in enhancing drug delivery into tumours. Here we show, using RNAi screening and subsequent validation studies, that NRP1-mediated endocytosis of CendR peptides is distinct from known endocytic pathways. Ultrastructurally, CendR endocytosis resembles macropinocytosis, but is mechanistically different. We also show that nutrient-sensing networks such as mTOR signalling regulate CendR endocytosis and subsequent intercellular transport of CendR cargo, both of which are stimulated by nutrient depletion. As CendR is a bulk transport pathway, our results suggest a role for it in nutrient transport; CendR-enhanced drug delivery then makes use of this natural pathway.
A Facile and Promising Delivery Platform for siRNA to Solid Tumors.
Leng Q, Anand A, Mixson A Molecules. 2024; 29(23.
PMID: 39683699 PMC: 11643702. DOI: 10.3390/molecules29235541.
Research Progress on Cyclic-Peptide Functionalized Nanoparticles for Tumor-Penetrating Delivery.
Wang C, Shen Z, Chen Y, Wang Y, Zhou X, Chen X Int J Nanomedicine. 2024; 19:12633-12652.
PMID: 39624118 PMC: 11609414. DOI: 10.2147/IJN.S487303.
Enhancing Tumor Targeted Therapy: The Role of iRGD Peptide in Advanced Drug Delivery Systems.
Nikitovic D, Kukovyakina E, Berdiaki A, Tzanakakis A, Luss A, Vlaskina E Cancers (Basel). 2024; 16(22).
PMID: 39594723 PMC: 11592346. DOI: 10.3390/cancers16223768.
Dynamin independent endocytosis is an alternative cell entry mechanism for multiple animal viruses.
Ojha R, Jiang A, Mantyla E, Quirin T, Modhira N, Witte R PLoS Pathog. 2024; 20(11):e1012690.
PMID: 39541404 PMC: 11594517. DOI: 10.1371/journal.ppat.1012690.
RGD-based self-assembling nanodrugs for improved tumor therapy.
Wang B, Tang D, Cui J, Jiang H, Yu J, Guo Z Front Pharmacol. 2024; 15:1477409.
PMID: 39411070 PMC: 11473307. DOI: 10.3389/fphar.2024.1477409.